Skip to content

Saint Polois

Les habitants vous parlent

Article 16 of the French Civil Code: Understanding the Protection of Human Dignity and Integrity

When a laboratory wants to conduct research on human embryos, it comes up against a three-line text that determines everything…

Juge française en robe noire tenant un livre de droit dans une salle d'audience en bois, symbolisant la dignité humaine et la protection juridique du Code civil
5 min read

When a laboratory wants to conduct research on human embryos, it comes up against a three-line provision that determines everything else: Article 16 of the French Civil Code.

This provision states that the law upholds the primacy of the person, prohibits any infringement of human dignity, and guarantees respect for human beings from the beginning of life. It is the foundation of French bioethics rules—and the hurdle researchers must clear before carrying out any work on living matter.

Biomedical research and Article 16 of the French Civil Code: where the line is drawn

The Bioethics Act of 2 August 2021 amended the framework governing research on embryos. The French Public Health Code now provides that embryos no longer suitable for transfer or storage may be used for research, with the written consent of the people concerned and subject to strict conditions.

Article L. 2141-3 of the same code requires the number of embryos created as part of medically assisted reproduction (MAR) to be limited to what is strictly necessary, taking into account the medical techniques used.

This is where the heart of the balancing act lies: Article 16 does not block research; it regulates it. The principle of dignity prohibits treating an embryo as mere laboratory material. The legislature has therefore established safeguards: prior consent, a demonstrated medical purpose, and no available alternative.

The 2021 Act also introduced a review mechanism. An assessment report on these provisions was due to be submitted to Parliament by 31 December 2025. This monitoring shows that bioethics rules are not set in stone but are periodically reviewed by the legislature.

Article 16 cannot be read in isolation. In the same chapter, entitled “Respect for the Human Body,” the Civil Code sets out complementary provisions on inviolability, infringements of bodily integrity, and practices involving parts of the body. In particular, Articles 16-1-1 and 16-4 of the Civil Code specify the respect owed to the human body after death and prohibit eugenic practices—both direct extensions of the principle set out in Article 16.

Group of adult legal professionals gathered around a conference table at a Paris law firm, reviewing documents relating to human integrity and dignity

Human dignity and bodily integrity: what the provision protects in practice

Article 16 of the French Civil Code is based on three practical principles that apply in a wide range of situations.

  • Primacy of the person: no collective interest—scientific, economic, or security-related—can justify an infringement of an individual’s dignity. An employer cannot require an employee to undergo a genetic test, and an insurer cannot make a policy conditional on screening.
  • Respect for human beings from the beginning of life: this principle underpins the law on reproduction. It explains why creating embryos solely for commercial or industrial purposes remains prohibited under French law.
  • Guarantee of dignity: the French Constitutional Council has relied on this concept to strike down legislative provisions. It applies both to living people and to the treatment of bodies after death, under Article 16-1-1 of the Civil Code.

In practice, Article 16 is cited in a range of legal disputes, including challenges to biological samples taken without consent, disputes over organ donation, and appeals against research protocols deemed to undermine human dignity.

Consent and the inviolability of the human body: when an infringement is lawful

The inviolability of the human body, established by Article 16-1 of the Civil Code, is not absolute. The law permits certain infringements, provided they comply with a specific framework.

The first requirement is the person’s free and informed consent. Surgery, a blood draw, an organ donation: legally, each of these acts constitutes an infringement of bodily integrity. Consent is what makes it lawful.

The second requirement is medical necessity. Article 16-3 of the Civil Code provides that bodily integrity may be infringed only where medically necessary for the person concerned or, exceptionally, in the therapeutic interests of another person. Bone marrow donation falls into this second category.

The third requirement is the principle that the human body has no commercial value. The human body, its parts, and its products cannot be subject to property rights. You cannot sell a kidney or patent a raw genetic sequence. This rule faces challenges as biotechnology advances: whether certain processes using parts of the human body can be patented remains a point of tension between civil law and intellectual property law.

The specific case of criminal law

Article 16 of the Civil Code does not define a criminal offence. Penalties for infringements of bodily integrity are set out in the Criminal Code. The Civil Code establishes the principle; the Criminal Code enforces it. This distinction explains why a doctor who operates without consent may face both a civil claim for damages and criminal prosecution for intentional assault.

Older man reading a legal document in the marble corridor of a French courthouse, evoking the protection of dignity and fundamental rights under Article 16 of the Civil Code

Protecting human dignity and bioethics law: an evolving framework

The 2021 Bioethics Act expanded access to MAR while strengthening the information provided to people about what happens to stored embryos. It requires detailed, regular information about the available options: continued storage, donation for research, donation to another couple, or ending storage.

The number of embryos created is limited to what is strictly necessary, a rule that follows directly from the respect owed to human beings from the beginning of life, as set out in Article 16. Creating surplus embryos to improve statistical chances would conflict with this principle.

Article 16 extends beyond the medical field. It has been invoked in cases concerning respect for dignity in detention, the treatment of people at the end of life, and the protection of the image of a deceased person. The provision serves as a foundational principle whose applications continue to expand as society and technology evolve.

French law has chosen not to set bioethics rules in stone. The periodic review clause, together with the assessment report required under the 2021 Act, sustains a dialogue between the principle of dignity and the realities of research. Article 16 remains the starting point for this balance, but it is in the provisions that build on it that decisions are made, case by case, about how to balance the protection of individuals with medical progress.

Article 16 of the French Civil Code: Understanding the Protection of Human Dignity and Integrity